
<!DOCTYPE html>
<html>
<meta charset="UTF-8">
<head>
  <title>Topic 14 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 15 - 15 Topics</title>

<style>
table {
  font-family: "Trebuchet MS", Arial, Helvetica, sans-serif;
  border-collapse: collapse;
  width: 100%;
}

td, th {
  border: 1px solid #ddd;
  padding: 8px;
}

tr:nth-child(even){background-color: #f2f2f2;}

tr:hover {background-color: #ddd;}

th {
  padding-top: 12px;
  padding-bottom: 12px;
  text-align: left;
  background-color: #0099FF;
  color: white;
}
</style>

</head>
<body>
<h2>Topic 14 -- Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 15 - 15 Topics</h2>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>cite ad</th>
      <th>title</th>
      <th>authors</th>
      <th>publish year</th>
      <th>publish time</th>
      <th>dataset</th>
      <th>abstract mentions covid</th>
      <th>pmcid</th>
      <th>pubmed id</th>
      <th>doi</th>
      <th>cord uid</th>
      <th>topic weight</th>
      <th>Similarity scispacy</th>
      <th>Similarity specter</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th id="3cjr1rol";>1</th>
      <td>Chan_2018</td>
      <td>Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations</td>
      <td>Chan, Marion M.; Chen, Rensa; Fong, Dunne</td>
      <td>2018</td>
      <td>2018-10-01</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117025" target="_blank">PMC7117025</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/29960048.0" target="_blank">29960048.0</a></td>
      <td><a href="https://doi.org/10.1016/j.canlet.2018.06.034" target="_blank">10.1016/j.canlet.2018.06.034</a></td>
      <td>3cjr1rol</td>
      <td>0.705244</td>
      <td></td>
      <td><a href="Topic_14.html#can4cvkx">Chen_2019</a></td>
    </tr>
    <tr>
      <th id="r1xxiy0v";>2</th>
      <td>Goldenberg_2008</td>
      <td>Strategies for the Identification of novel inhibitors of deubiquitinating enzymes</td>
      <td>Goldenberg, Seth J; McDermott, Jeffrey L; Butt, Tauseef R; Mattern, Michael R; Nicholson, Benjamin</td>
      <td>2008</td>
      <td>2008-09-19</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061546" target="_blank">PMC3061546</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/18793145.0" target="_blank">18793145.0</a></td>
      <td><a href="https://doi.org/10.1042/bst0360828" target="_blank">10.1042/bst0360828</a></td>
      <td>r1xxiy0v</td>
      <td>0.557480</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="vm8os5gn";>3</th>
      <td>Farshi_2015</td>
      <td>Deubiquitinases (DUBs) and DUB inhibitors: a patent review</td>
      <td>Farshi, Pershang; Deshmukh, Rahul R.; Nwankwo, Joseph O.; Arkwright, Richard T.; Cvek, Boris; Liu, Jinbao; Dou, Q. Ping</td>
      <td>2015</td>
      <td>2015-06-16</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834700" target="_blank">PMC4834700</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/26077642.0" target="_blank">26077642.0</a></td>
      <td><a href="https://doi.org/10.1517/13543776.2015.1056737" target="_blank">10.1517/13543776.2015.1056737</a></td>
      <td>vm8os5gn</td>
      <td>0.547068</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="sgh6adb2";>4</th>
      <td>Mattern_2012</td>
      <td>Ubiquitin-based anticancer therapy: Carpet bombing with proteasome inhibitors vs surgical strikes with E1, E2, E3, or DUB inhibitors</td>
      <td>Mattern, Michael R.; Wu, Jian; Nicholson, Benjamin</td>
      <td>2012</td>
      <td>2012-11-30</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127515" target="_blank">PMC7127515</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/22610084.0" target="_blank">22610084.0</a></td>
      <td><a href="https://doi.org/10.1016/j.bbamcr.2012.05.005" target="_blank">10.1016/j.bbamcr.2012.05.005</a></td>
      <td>sgh6adb2</td>
      <td>0.547008</td>
      <td></td>
      <td><a href="Topic_14.html#can4cvkx">Chen_2019</a></td>
    </tr>
    <tr>
      <th id="r4on3lpr";>5</th>
      <td>Veggiani_2019</td>
      <td>Emerging drug development technologies targeting ubiquitination for cancer therapeutics</td>
      <td>Veggiani, Gianluca; Gerpe, María Carla Rosales; Sidhu, Sachdev S.; Zhang, Wei</td>
      <td>2019</td>
      <td>2019-07-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112620" target="_blank">PMC7112620</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/30851297.0" target="_blank">30851297.0</a></td>
      <td><a href="https://doi.org/10.1016/j.pharmthera.2019.03.003" target="_blank">10.1016/j.pharmthera.2019.03.003</a></td>
      <td>r4on3lpr</td>
      <td>0.518061</td>
      <td></td>
      <td><a href="Topic_14.html#o44dtozb">Edelmann_2011</a>, <a href="Topic_14.html#can4cvkx">Chen_2019</a></td>
    </tr>
    <tr>
      <th id="k86hzbbx";>6</th>
      <td>Fan_H_2017</td>
      <td>Selective inhibition of Ebola entry with selective estrogen receptor modulators by disrupting the endolysosomal calcium</td>
      <td>Fan, Hanlu; Du, Xiaohong; Zhang, Jingyuan; Zheng, Han; Lu, Xiaohui; Wu, Qihui; Li, Haifeng; Wang, Han; Shi, Yi; Gao, George; Zhou, Zhuan; Tan, Dun-Xian; Li, Xiangdong</td>
      <td>2017</td>
      <td>2017-01-24</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259750" target="_blank">PMC5259750</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/28117364.0" target="_blank">28117364.0</a></td>
      <td><a href="https://doi.org/10.1038/srep41226" target="_blank">10.1038/srep41226</a></td>
      <td>k86hzbbx</td>
      <td>0.511299</td>
      <td></td>
      <td><a href="Topic_14.html#can4cvkx">Chen_2019</a></td>
    </tr>
    <tr>
      <th id="qbvqny97";>7</th>
      <td>de_Graaf_2018</td>
      <td>Armed oncolytic viruses: A kick-start for anti-tumor immunity</td>
      <td>de Graaf, J.F.; de Vor, L.; Fouchier, R.A.M.; van den Hoogen, B.G.</td>
      <td>2018</td>
      <td>2018-06-30</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108398" target="_blank">PMC7108398</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/29576283.0" target="_blank">29576283.0</a></td>
      <td><a href="https://doi.org/10.1016/j.cytogfr.2018.03.006" target="_blank">10.1016/j.cytogfr.2018.03.006</a></td>
      <td>qbvqny97</td>
      <td>0.501562</td>
      <td></td>
      <td><a href="Topic_01.html#83yu8m9v">Kaufman_2015</a>, <a href="Topic_02.html#8jin6oru">Martínez_2008</a></td>
    </tr>
    <tr>
      <th id="oa3x63xd";>8</th>
      <td>Klein_2009</td>
      <td>HIV Coreceptors and Their Roles in Leukocyte Trafficking During Neuroinflammatory Diseases</td>
      <td>Klein, Robyn S.; McCandless, Erin E.</td>
      <td>2009</td>
      <td>2009-06-24</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120588" target="_blank">PMC7120588</a></td>
      <td></td>
      <td><a href="https://doi.org/10.1007/978-1-4419-0793-6_6" target="_blank">10.1007/978-1-4419-0793-6_6</a></td>
      <td>oa3x63xd</td>
      <td>0.481965</td>
      <td></td>
      <td><a href="Topic_08.html#qhhdjgeq">Zhu_X_2015</a></td>
    </tr>
    <tr>
      <th id="pl6uf13v";>9</th>
      <td>Russell_2007</td>
      <td>Viruses as anticancer drugs</td>
      <td>Russell, Stephen J.; Peng, Kah-Whye</td>
      <td>2007</td>
      <td>2007-07-01</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125087" target="_blank">PMC3125087</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/17573126.0" target="_blank">17573126.0</a></td>
      <td><a href="https://doi.org/10.1016/j.tips.2007.05.005" target="_blank">10.1016/j.tips.2007.05.005</a></td>
      <td>pl6uf13v</td>
      <td>0.472332</td>
      <td><a href="Topic_01.html#r4snyxr9">Li_C_2019</a>, <a href="Topic_02.html#ali14j7x">Wisskirchen_2014</a>, <a href="Topic_15.html#s6x0igia">Dove_2004</a></td>
      <td><a href="Topic_01.html#83yu8m9v">Kaufman_2015</a></td>
    </tr>
    <tr>
      <th id="o44dtozb";>10</th>
      <td>Edelmann_2011</td>
      <td>Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases</td>
      <td>Edelmann, Mariola J.; Nicholson, Benjamin; Kessler, Benedikt M.</td>
      <td>2011</td>
      <td>2011-11-23</td>
      <td>NONCOMM</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219211" target="_blank">PMC3219211</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/22088887.0" target="_blank">22088887.0</a></td>
      <td><a href="https://doi.org/10.1017/s1462399411002031" target="_blank">10.1017/s1462399411002031</a></td>
      <td>o44dtozb</td>
      <td>0.470645</td>
      <td></td>
      <td><a href="Topic_14.html#can4cvkx">Chen_2019</a>, <a href="Topic_14.html#r4on3lpr">Veggiani_2019</a></td>
    </tr>
    <tr>
      <th id="rkb9z5t9";>11</th>
      <td>Wanve_2018</td>
      <td>Therapeutic spectrum of interferon‐β in ischemic stroke</td>
      <td>Wanve, Madhuri; Kaur, Harpreet; Sarmah, Deepaneeta; Saraf, Jackson; Pravalika, Kanta; Vats, Kanchan; Kalia, Kiran; Borah, Anupom; Yavagal, Dileep R.; Dave, Kunjan R.; Bhattacharya, Pallab</td>
      <td>2018</td>
      <td>2018-10-15</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167007" target="_blank">PMC7167007</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/30320448.0" target="_blank">30320448.0</a></td>
      <td><a href="https://doi.org/10.1002/jnr.24333" target="_blank">10.1002/jnr.24333</a></td>
      <td>rkb9z5t9</td>
      <td>0.470645</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="9b11c0od";>12</th>
      <td>Antonelli_2015</td>
      <td>Twenty-five years of type I interferon-based treatment: A critical analysis of its therapeutic use</td>
      <td>Antonelli, Guido; Scagnolari, Carolina; Moschella, Federica; Proietti, Enrico</td>
      <td>2015</td>
      <td>2015-04-30</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108252" target="_blank">PMC7108252</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/25578520.0" target="_blank">25578520.0</a></td>
      <td><a href="https://doi.org/10.1016/j.cytogfr.2014.12.006" target="_blank">10.1016/j.cytogfr.2014.12.006</a></td>
      <td>9b11c0od</td>
      <td>0.464892</td>
      <td></td>
      <td><a href="Topic_02.html#8jin6oru">Martínez_2008</a></td>
    </tr>
    <tr>
      <th id="crl8bxo1";>13</th>
      <td>Singh_2016</td>
      <td>Deubiquitinases and cancer: A snapshot</td>
      <td>Singh, Nishant; Singh, Anuradha Bharara</td>
      <td>2016</td>
      <td>2016-07-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128910" target="_blank">PMC7128910</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/27211605.0" target="_blank">27211605.0</a></td>
      <td><a href="https://doi.org/10.1016/j.critrevonc.2016.04.018" target="_blank">10.1016/j.critrevonc.2016.04.018</a></td>
      <td>crl8bxo1</td>
      <td>0.436146</td>
      <td></td>
      <td><a href="Topic_14.html#r1xxiy0v">Goldenberg_2008</a></td>
    </tr>
    <tr>
      <th id="2ajvf1vx";>14</th>
      <td>Bailly_2019</td>
      <td>Cepharanthine: An update of its mode of action, pharmacological properties and medical applications</td>
      <td>Bailly, Christian</td>
      <td>2019</td>
      <td>2019-09-30</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126782" target="_blank">PMC7126782</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31132753.0" target="_blank">31132753.0</a></td>
      <td><a href="https://doi.org/10.1016/j.phymed.2019.152956" target="_blank">10.1016/j.phymed.2019.152956</a></td>
      <td>2ajvf1vx</td>
      <td>0.435789</td>
      <td></td>
      <td><a href="Topic_14.html#can4cvkx">Chen_2019</a></td>
    </tr>
    <tr>
      <th id="9lkd4o3l";>15</th>
      <td>Ding_2019</td>
      <td>Cellular Signaling Analysis shows antiviral, ribavirin-mediated ribosomal signaling modulation</td>
      <td>Ding, Xianting; Krutzik, Peter O.; Ghaffari, Amir Ali; Zhaozhi, Yixiu; Miranda, Daniel; Cheng, Genhong; Ho, Chih-Ming; Nolan, Garry P.; Sanchez, David Jesse</td>
      <td>2019</td>
      <td>2019-11-30</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114107" target="_blank">PMC7114107</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31513822.0" target="_blank">31513822.0</a></td>
      <td><a href="https://doi.org/10.1016/j.antiviral.2019.104598" target="_blank">10.1016/j.antiviral.2019.104598</a></td>
      <td>9lkd4o3l</td>
      <td>0.394551</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="0gtkqn81";>16</th>
      <td>Zhou_2011</td>
      <td>Parkinson disease drug screening based on the interaction between D(2) dopamine receptor and beta-arrestin 2 detected by capillary zone electrophoresis</td>
      <td>Zhou, Zheng; Liao, Jun-Ming; Zhang, Peng; Fan, Jun-Bao; Chen, Jie; Liang, Yi</td>
      <td>2011</td>
      <td>2011-11-01</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875183" target="_blank">PMC4875183</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/22180089.0" target="_blank">22180089.0</a></td>
      <td><a href="https://doi.org/10.1007/s13238-011-1096-0" target="_blank">10.1007/s13238-011-1096-0</a></td>
      <td>0gtkqn81</td>
      <td>0.374749</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="can4cvkx";>17</th>
      <td>Chen_2019</td>
      <td>The Molecular Aspect of Antitumor Effects of Protease Inhibitor Nafamostat Mesylate and Its Role in Potential Clinical Applications</td>
      <td>Chen, Xi; Xu, Zhijie; Zeng, Shuangshuang; Wang, Xiang; Liu, Wanli; Qian, Long; Wei, Jie; Yang, Xue; Shen, Qiuying; Gong, Zhicheng; Yan, Yuanliang</td>
      <td>2019</td>
      <td>2019-09-03</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733886" target="_blank">PMC6733886</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31552177.0" target="_blank">31552177.0</a></td>
      <td><a href="https://doi.org/10.3389/fonc.2019.00852" target="_blank">10.3389/fonc.2019.00852</a></td>
      <td>can4cvkx</td>
      <td>0.334203</td>
      <td></td>
      <td><a href="Topic_14.html#2ajvf1vx">Bailly_2019</a></td>
    </tr>
    <tr>
      <th id="5ts3kk10";>18</th>
      <td>Kim_D_2019</td>
      <td>Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells</td>
      <td>Kim, Dong Eon; Min, Jung Sun; Jang, Min Seong; Lee, Jun Young; Shin, Young Sup; Park, Chul Min; Song, Jong Hwan; Kim, Hyoung Rae; Kim, Seungtaek; Jin, Young-Hee; Kwon, Sunoh</td>
      <td>2019</td>
      <td>2019-11-04</td>
      <td>COMM-USE</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921063" target="_blank">PMC6921063</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/31690059.0" target="_blank">31690059.0</a></td>
      <td><a href="https://doi.org/10.3390/biom9110696" target="_blank">10.3390/biom9110696</a></td>
      <td>5ts3kk10</td>
      <td>0.327840</td>
      <td></td>
      <td><a href="Topic_03.html#wgzpd6te">Wu_H_2016</a></td>
    </tr>
    <tr>
      <th id="nf6ouaq3";>19</th>
      <td>Es-Saad_2012</td>
      <td>Regulators of innate immunity as novel targets for panviral therapeutics</td>
      <td>Es-Saad, Salwa; Tremblay, Nicolas; Baril, Martin; Lamarre, Daniel</td>
      <td>2012</td>
      <td>2012-10-31</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102864" target="_blank">PMC7102864</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/23017246.0" target="_blank">23017246.0</a></td>
      <td><a href="https://doi.org/10.1016/j.coviro.2012.08.009" target="_blank">10.1016/j.coviro.2012.08.009</a></td>
      <td>nf6ouaq3</td>
      <td>0.318214</td>
      <td></td>
      <td><a href="Topic_02.html#8jin6oru">Martínez_2008</a></td>
    </tr>
    <tr>
      <th id="wz4nsbtc";>20</th>
      <td>Keating_2011</td>
      <td>Phosphorylation events during viral infections provide potential therapeutic targets</td>
      <td>Keating, Julie A.; Striker, Rob</td>
      <td>2011</td>
      <td>2011-11-24</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334462" target="_blank">PMC3334462</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/22113983.0" target="_blank">22113983.0</a></td>
      <td><a href="https://doi.org/10.1002/rmv.722" target="_blank">10.1002/rmv.722</a></td>
      <td>wz4nsbtc</td>
      <td>0.314069</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <th id="hcqe6xsr";>21</th>
      <td>Harrington_2010</td>
      <td>Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics</td>
      <td>Harrington, K.J.; Vile, R.G.; Melcher, A.; Chester, J.; Pandha, H.S.</td>
      <td>2010</td>
      <td>2010-06-30</td>
      <td>None</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915505" target="_blank">PMC3915505</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/20223697.0" target="_blank">20223697.0</a></td>
      <td><a href="https://doi.org/10.1016/j.cytogfr.2010.02.006" target="_blank">10.1016/j.cytogfr.2010.02.006</a></td>
      <td>hcqe6xsr</td>
      <td>0.305991</td>
      <td></td>
      <td><a href="Topic_02.html#8jin6oru">Martínez_2008</a>, <a href="Topic_14.html#can4cvkx">Chen_2019</a></td>
    </tr>
    <tr>
      <th id="b1e0bbrp";>22</th>
      <td>Li_S_2017</td>
      <td>Interferon-omega: Current status in clinical applications</td>
      <td>Li, Shi-fang; Zhao, Fu-rong; Shao, Jun-jun; Xie, Yin-li; Chang, Hui-yun; Zhang, Yong-guang</td>
      <td>2017</td>
      <td>2017-11-30</td>
      <td>PMC</td>
      <td>N</td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106160" target="_blank">PMC7106160</a></td>
      <td><a href="https://www.ncbi.nlm.nih.gov/pubmed/28957693.0" target="_blank">28957693.0</a></td>
      <td><a href="https://doi.org/10.1016/j.intimp.2017.08.028" target="_blank">10.1016/j.intimp.2017.08.028</a></td>
      <td>b1e0bbrp</td>
      <td>0.301004</td>
      <td><a href="Topic_02.html#t2vdzppd">Jerome_2005</a></td>
      <td><a href="Topic_03.html#zfpcuhpy">Doménech_2011</a></td>
    </tr>
  </tbody>
</table>
</body>
</html>
